CVRx, Inc. (CVRX) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Please stand by, your program is about to begin. If you need assistance during your conference today, please press star zero. Good day, everyone, and welcome to today's CVRX Q1 2025 earnings call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing star 1 on your telephone keypad. Please note this call is being recorded. I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Mike Vallee from ICR Healthcare. Please go ahead. Good afternoon. Thank you for joining us today for CBRX's first quarter 2025 earnings conference call. Joining me on today's call are the company's president and chief executive officer, Kevin Hikes, and chief financial officer, Jared O'Shine. The remarks today will contain foreign-looking statements, including statements about financial guidance. These statements are based on plans and expectations as of today, which may change over time. In addition, actual results could differ materially due to a number of risks and uncertainties, including those identified in the earnings release issued prior to this call and in the company's SEC filings. I would now like to turn the call over to CBRX's President and Chief Executive Officer, Kevin Hikes. Thanks, Mike. Good afternoon, and thank you for joining us for our first quarter earnings call. Revenue in the quarter was $12.3 million, representing 15% growth over the prior year quarter, consistent with the preliminary results shared in early April. While we continue to make significant progress in driving Barrow-Stim to become the standard of care for heart failure, our revenue performance fell ...